Lexaria Bioscience (LEXX) Treasury Shares (2024)

Lexaria Bioscience's (LEXX) quarterly Treasury Shares came in at $889272.0 in Q3 2024, little changed quarter-over-quarter from $889272.0 in Q2 2024.

Lexaria Bioscience (LEXX) Treasury Shares (2024) Analysis & Trends

Lexaria Bioscience has disclosed Treasury Shares across 1 years of filings, most recently posting $889272.0 for Q3 2024.

Treasury Shares for Q3 2024 came in at $889272.0, changed N/A year-over-year; the trailing twelve-month figure through Aug 2024 was $889272.0 (changed N/A YoY), and the FY2024 annual result was $889272.0, changed N/A from the prior year.
Treasury Shares came in at $889272.0 for Q3 2024 at Lexaria Bioscience, roughly flat from $889272.0 in the prior quarter.
In the past five years, Treasury Shares ranged from a high of $889272.0 in Q2 2024 to a low of $889272.0 in Q2 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Alterity Therapeutics	719,706.53 Bn	719,706.50 Bn	-	-
2	Belite Bio	55,800.00 Bn	55,800.00 Bn	-	-
3	Quantum Biopharma	18,182.30 Bn	18,182.29 Bn	-	-
4	Legend Biotech	3,154.00 Bn	3,153.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,844.30 Bn	1,844.29 Bn	-	-
6	Evaxion A	1,567.96 Bn	1,567.94 Bn	-	-
7	Psyence Biomedical	251.43 Bn	251.42 Bn	-	1.48 Mn
8	Vertex Pharmaceuticals	112.56 Bn	105.31 Bn	2.59 Bn	700,000.00
9	Abivax	94.37 Bn	94.37 Bn	-	-
10	Lexaria Bioscience	7.17 Mn	1.65 Mn	20,000.00	-

Download Data